『Executive Insights for Life Sciences Innovators』のカバーアート

Executive Insights for Life Sciences Innovators

Executive Insights for Life Sciences Innovators

著者： GeneCoda® Executive Search
無料で聴く

このコンテンツについて

 Executive Insights features conversations with visionary leaders shaping the future of biotech, pharma, medtech, diagnostics, and tools. Hear from CEOs, entrepreneurs, and investors about building companies, raising capital, and driving innovation. Whether you are growing a startup or scaling a global life sciences business, these candid discussions deliver the insights you need to succeed.GeneCoda® Executive Search 生物科学 科学
エピソード
  • Mark Stead | Atomic AI – Harnessing Artificial Intelligence and Structural Biology to Unlock RNA Therapeutics

    Mark Stead | Atomic AI – Harnessing Artificial Intelligence and Structural Biology to Unlock RNA Therapeutics
    2025/09/08

    In this episode of Executive Insights for Life Sciences Innovators, we speak with Mark Stead of Atomic AI, a biotech harnessing artificial intelligence and structural biology to unlock RNA’s therapeutic potential. Mark shares how Atomic AI is building a discovery platform to model RNA structures with unprecedented accuracy, opening the door to new classes of medicines for oncology, rare diseases, and beyond.

    Learn more at genecoda.com.

    Originally recorded and streamed on YouTube Live on August 22, 2025.
    続きを読む 一部表示
    37 分
  • Larry Tiffany | CEO, GenrAb – Developing Fully Human Neuroprotective Antibodies for Neurodegenerative Diseases

    Larry Tiffany | CEO, GenrAb – Developing Fully Human Neuroprotective Antibodies for Neurodegenerative Diseases
    2025/09/08

    In this episode of Executive Insights for Life Sciences Innovators, we sit down with Larry Tiffany, CEO of GenrAb, to explore how the company is developing fully human neuroprotective antibodies to address neurodegenerative diseases such as ALS, Parkinson’s, and Alzheimer’s. Larry discusses GenrAb’s scientific approach, the promise of neuroprotection in slowing disease progression, and the challenges of advancing novel biologics in today’s biotech landscape.

    Learn more at genecoda.com.

    Originally recorded and streamed on YouTube Live on June 20, 2025.
    続きを読む 一部表示
    25 分
  • Saurabh Johri | Chief Business Officer, Catena Biosciences – Revolutionizing Protein Conjugation for Next-Generation Therapeutics

    Saurabh Johri | Chief Business Officer, Catena Biosciences – Revolutionizing Protein Conjugation for Next-Generation Therapeutics
    2025/09/08

    In this episode of Executive Insights for Life Sciences Innovators, we sit down with Saurabh Johri, Chief Business Officer at Catena Biosciences, a pioneering company revolutionizing protein conjugation technologies for next-generation therapeutics. Saurabh shares insights on Catena’s platform, its potential to reshape therapeutic development, and the company’s vision for advancing precision medicine through novel protein engineering approaches.

    Learn more at genecoda.com.

    Originally recorded and streamed on YouTube Live on June 6, 2025.
    続きを読む 一部表示
    33 分
まだレビューはありません